Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes (EXPLORE)

Alexion Pharmaceuticals

Status: Completed

Conditions: Hemoglobinuria

Study type: Observational

Funder types: Industry

Identifiers

NCT01192425

P06-001

Details and patient eligibility

About

Examine red and white blood cells of PNH patients with bone marrow failure syndromes.

Enrollment: 5,580 patients

Sex: All

Ages: 10+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• At least 10 years of age.
• Has aplastic anemia, myelodysplastic syndromes or other bone marrow failure syndromes

Exclusion criteria

• Has any condition that might interfere with the patient's participation